Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Giovanni B. Frisoni, Daniele Altomare, Dietmar Rudolf Thal, et al.
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 1, pp. 53-66
Open Access | Times Cited: 326

Showing 1-25 of 326 citing articles:

ApoE Cascade Hypothesis in the pathogenesis of Alzheimer’s disease and related dementias
Yuka A. Martens, Na Zhao, Chia‐Chen Liu, et al.
Neuron (2022) Vol. 110, Iss. 8, pp. 1304-1317
Open Access | Times Cited: 209
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 114
Pesticides impacts on human health and the environment with their mechanisms of action and possible countermeasures
Md Faruque Ahmad, Fakhruddin Ali Ahmad, Abdulrahman A. Alsayegh, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e29128-e29128
Open Access | Times Cited: 108
APOE4 homozygosity represents a distinct genetic form of Alzheimer’s disease
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1284-1291
Closed Access | Times Cited: 108
The amyloid cascade hypothesis: an updated critical review
Kasper P. Kepp, Nikolaos K. Robakis, Poul Flemming Høilund‐Carlsen, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 3969-3990
Open Access | Times Cited: 106
Implications of Gut Microbiota in Neurodegenerative Diseases
Haoming Zhang, Yijia Chen, Zifan Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 102
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 90
Genome-wide association studies for Alzheimer’s disease: bigger is not always better
Valentina Escott‐Price, John Hardy
Brain Communications (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 84
Exercise suppresses neuroinflammation for alleviating Alzheimer’s disease
Minghui Wang, Hu Zhang, Jiling Liang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 80
Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications
Nikita A. Frolov, A. N. Vereshchagin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2937-2937
Open Access | Times Cited: 77
Step by step: towards a better understanding of the genetic architecture of Alzheimer’s disease
Jean‐Charles Lambert, Alfredo Ramı́rez, Benjamin Grenier‐Boley, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 7, pp. 2716-2727
Open Access | Times Cited: 46
Shared genetic risk loci between Alzheimer’s disease and related dementias, Parkinson’s disease, and amyotrophic lateral sclerosis
Michael Wainberg, Shea J. Andrews, Shreejoy J. Tripathy
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 45
A natural polyphenol activates and enhances GPX4 to mitigate amyloid-β induced ferroptosis in Alzheimer's disease
Prayasee Baruah, Hariharan Moorthy, Madhu Ramesh, et al.
Chemical Science (2023) Vol. 14, Iss. 35, pp. 9427-9438
Open Access | Times Cited: 44
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
Bruno Dubois, Nicolas Villain, Lon S. Schneider, et al.
JAMA Neurology (2024)
Closed Access | Times Cited: 39
Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums
Anita Kamondi, Madeleine Grigg‐Damberger, Wolfgang Löscher, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 3, pp. 162-182
Closed Access | Times Cited: 30
Data-driven modelling of neurodegenerative disease progression: thinking outside the black box
Alexandra L. Young, Neil P. Oxtoby, Sara Garbarino, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 111-130
Closed Access | Times Cited: 27
A synergetic turn in cognitive neuroscience of brain diseases
Agustín Ibáñez, Morten L. Kringelbach, Gustavo Deco
Trends in Cognitive Sciences (2024) Vol. 28, Iss. 4, pp. 319-338
Closed Access | Times Cited: 21
p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial
Hayley R. C. Shanks, Kewei Chen, Eric M. Reiman, et al.
Nature Medicine (2024) Vol. 30, Iss. 6, pp. 1761-1770
Open Access | Times Cited: 17
Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways
Oliwia Koszła, Przemysław Sołek
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 16
Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Yacoubou Abdoul Razak Mahaman, Kidane Siele Embaye, Huang Fang, et al.
Ageing Research Reviews (2021) Vol. 74, pp. 101544-101544
Closed Access | Times Cited: 100
High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
Nicolas Villain, Vincent Planche, Raymond Levy
Revue Neurologique (2022) Vol. 178, Iss. 10, pp. 1011-1030
Open Access | Times Cited: 63
Genuine high-order interactions in brain networks and neurodegeneration
Rubén Herzog, Fernando E. Rosas, Robert Whelan, et al.
Neurobiology of Disease (2022) Vol. 175, pp. 105918-105918
Open Access | Times Cited: 62
Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites
Felix Meier‐Stephenson, Vanessa Meier‐Stephenson, Michael D. Carter, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 58
Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
Carmen Romero‐Molina, Francesca Garretti, Shea J. Andrews, et al.
Neuron (2022) Vol. 110, Iss. 21, pp. 3513-3533
Open Access | Times Cited: 53
The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
Dietmar Rudolf Thal, Sandra O. Tomé
Brain Research Bulletin (2022) Vol. 190, pp. 204-217
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top